Tag Archives: SARS-CoV-2

What Comes After COVID

No Gravatar

Yan Xie and Dr. Ziyad Al-Aly (the latter is the Director of Research, VA St. Louis Health Care System) combed through the Veteran’s Affairs national database, examining the records of some 181, 280 participants who developed COVID-19 between 1 March and 30 September 2021, and survived at least 30 days of the illness. These were compared to two control groups- 4,118,441 during the same time frame and a similar one (4,286,911 from 1 March 2018 and 30 September 2018) that manifested no evidence of COVID-19.  None of the participants had  diabetes before inclusion in the cohorts.

Continue reading What Comes After COVID

Share this:
Share this page via Email Share this page via Stumble Upon Share this page via Digg this Share this page via Facebook Share this page via Twitter
Share

Masks, yet again

No Gravatar

Here we are again. Shaking in our boots because of COVID-19.

Sure, this new variant (omicron) seems far less lethal, but it’s more prone to infect us. (That’s what happens when the SARS-CoV-2 virus adopts characteristics of the common cold virus. That’s what can happen when an uninoculated subject is invaded by the SARS-CoV-2 virus while suffering from – or about to – the common cold.)

Continue reading Masks, yet again

Share this:
Share this page via Email Share this page via Stumble Upon Share this page via Digg this Share this page via Facebook Share this page via Twitter
Share